Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Market Report Coverage - Femtech
Market Segmentation
ALYK, Inc., Aytu BioScience, Inc., Biowink GmbH, CORA, Flo Health, Inc., Bloomlife, Glow, Inc., Inne, Kasha, NaturalCycles Nordic AB, Plackal Tech, Ovia Health, Sustain Natural, The Flex Company, Thinx, Inc., Celmatix Inc., Conceivable Inc., Lia Diagnostics Inc., Lucina Health, Inc., Progny, Inc., Univfy Inc., among others
Key Questions Answered:
Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.
However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women centric start-ups have significantly multiplied in the recent years. This surge is also primarily attributed to the launch of fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.
Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering a financial support of $23 million.
As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period. One of the major driving factor for the market is increasing incidence of infectious and chronic diseases among the female population leading to surge in demand for effective and more personalized treatment. Furthermore, women’s health awareness has significantly increased in recent years. For an instance, it was not until 2004, the cardiovascular diseases were considered medically a threat to women’s health. However, campaigns such as the American Heart Association’s Go Red for Women campaign and the NHLBI’s Heart Truth program have significantly boosted the awareness related to life threatening diseases such as CVD.
Another reason driving the growth of the market is growing prevalence of infectious disease among females in low to middle-income countries due to an unhygienic environment. For an instance, in 2013, 60% of new HIV infections in population younger than 25 years occurred in girls and young women. Also, untreated syphilis in low- and middle-income countries still causes over 200?000 deaths every year.
However, some of the major challenges restraining the growth of the market are: creation of awareness among women, particularly in rural areas, unequal distribution of women as compared to men in investment community, and lack of understanding of women health issues by investors, among others.
Competitive Landscape
The Femtech market comprises over 200 start-ups worldwide, 92 percent of which are founded and led by women. Big names in these areas are developing entirely new solutions such as the Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker. While others focus on building tech platforms and subscription services to make existing products such as birth control and period products more easily accessible.
Although majority of Femtech firms are focusing on the millennials, there are also companies working for women at all ages. For example, Genneve, an online clinic aimed at aiding women entering menopause. Also, other companies such as Madorra and MenoGeni are developing devices and pharmaceutical alternatives to aid in the treatment of menopausal symptoms. Companies are extensively entering new women’s health spaces to stand out in the competition. Some of the emerging women’s heath spaces are osteoporosis, breast cancer, autoimmune conditions, stroke, thyroid issues, chronic fatigue, anxiety, and depression.
Market Report Coverage - Femtech
Market Segmentation
- Component – Mobile Apps, Connected Devices, Services, Others
- Application – Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Health, General Health and Wellness
- End Users- Individuals, Hospitals, Diagnostic Centers, and Fertility Clinics
- North America – U.S., Canada
- Europe – Germany, U.K., France, Spain, Netherlands, Sweden, Switzerland, Belgium
- Asia-Pacific – China, Japan, India, South Korea, and Australia
- Rest-of-the-World – Saudi Arabia, United Arab Emirates, Israel, South Africa, Brazil and Mexico
- Growing recognition of Women in the Domain of Technology
- Economic Burden of Women’s health is more than $500 Billion
- Explosion of wearable devices and increasing smartphone penetration among women
- Lack of women decision makers
- Societal taboos surrounding women’s health issues
- Absence of awareness among women in rural areas
- Lack of scientific studies to back industrial claims
- Investment in product development for maternal, pre- and neo-natal care
- Investment in sub-Saharan Africa
- Product development for menopause management
ALYK, Inc., Aytu BioScience, Inc., Biowink GmbH, CORA, Flo Health, Inc., Bloomlife, Glow, Inc., Inne, Kasha, NaturalCycles Nordic AB, Plackal Tech, Ovia Health, Sustain Natural, The Flex Company, Thinx, Inc., Celmatix Inc., Conceivable Inc., Lia Diagnostics Inc., Lucina Health, Inc., Progny, Inc., Univfy Inc., among others
Key Questions Answered:
- How has the market evolved in the last five years, and what are the awaited technological advancements in the field of Femtech?
- What are the major market drivers, challenges, and opportunities in the global Femtech market?
- What are the underlying structures resulting in the emerging trends within the Femtech industry?
- What was the market value of the leading segments of the global Femtech market in 2019?
- What are the influencing factors that may affect the market positioning of the key players?
- How is industry expected to evolve during the forecast period 2019-2030?
- What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
- What are the key business models employed by the femtech companies to standout in the evolving market?
- What is the growth potential of Femtech in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
- What are the key regulatory implications in developed and developing regions for Femtech?
- What was the funding trends for the Femtech companies in the last three years and how would the funding scenario change during the forecast period?
Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.
However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women centric start-ups have significantly multiplied in the recent years. This surge is also primarily attributed to the launch of fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.
Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering a financial support of $23 million.
As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period. One of the major driving factor for the market is increasing incidence of infectious and chronic diseases among the female population leading to surge in demand for effective and more personalized treatment. Furthermore, women’s health awareness has significantly increased in recent years. For an instance, it was not until 2004, the cardiovascular diseases were considered medically a threat to women’s health. However, campaigns such as the American Heart Association’s Go Red for Women campaign and the NHLBI’s Heart Truth program have significantly boosted the awareness related to life threatening diseases such as CVD.
Another reason driving the growth of the market is growing prevalence of infectious disease among females in low to middle-income countries due to an unhygienic environment. For an instance, in 2013, 60% of new HIV infections in population younger than 25 years occurred in girls and young women. Also, untreated syphilis in low- and middle-income countries still causes over 200?000 deaths every year.
However, some of the major challenges restraining the growth of the market are: creation of awareness among women, particularly in rural areas, unequal distribution of women as compared to men in investment community, and lack of understanding of women health issues by investors, among others.
Competitive Landscape
The Femtech market comprises over 200 start-ups worldwide, 92 percent of which are founded and led by women. Big names in these areas are developing entirely new solutions such as the Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker. While others focus on building tech platforms and subscription services to make existing products such as birth control and period products more easily accessible.
Although majority of Femtech firms are focusing on the millennials, there are also companies working for women at all ages. For example, Genneve, an online clinic aimed at aiding women entering menopause. Also, other companies such as Madorra and MenoGeni are developing devices and pharmaceutical alternatives to aid in the treatment of menopausal symptoms. Companies are extensively entering new women’s health spaces to stand out in the competition. Some of the emerging women’s heath spaces are osteoporosis, breast cancer, autoimmune conditions, stroke, thyroid issues, chronic fatigue, anxiety, and depression.
EXECUTIVE SUMMARY
1 PRODUCT DEFINITION
1.1 Inclusion and Exclusion
2 SCOPE OF THE STUDY
2.1 Key Questions Answered in the Report
3 RESEARCH METHODOLOGY
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Companies Profiled
3.5 Assumptions and Limitations
4 INDUSTRY ANALYSIS
4.1 Industry Trends
4.1.1 Underrepresentation of Women as Decision Makers
4.1.2 Pricing and Branding Strategies
4.1.3 Femtech in Emerging Economies
4.1.4 Growing Emphasis on Holistic Women Healthcare
4.1.5 Smart Medical Devices and Wearables
4.1.6 Destigmatizing Menstrual Health and Menopause
4.2 Femtech Innovation Tracker
4.2.1 Wearable Devices for Fertility Tracking
4.2.2 Vaginal Sensor for Fertility Cycle Monitoring
4.2.3 Leveraging Genomics and Big Data for Fertility Tracking and Menstrual Health
4.2.4 Wearables for Breast Cancer Screening
4.3 Regulatory Framework
4.3.1 Regulatory Framework in North America
4.3.2 Regulatory Framework in Europe
4.4 Funding Analysis
4.4.1 Femtech Received More Than $1 Billion Over the Last 5 Years
4.4.2 Notable Private Funding in Femtech
5 COMPETITIVE LANDSCAPE
5.1 Key Developments and Strategies
5.1.1 Funding
5.1.2 Collaborations and Partnerships
5.1.3 Product Launch and Upgradation
5.1.4 Mergers and Acquisitions
5.2 Business Model Analysis
5.2.1 One-for-One Give Back Model
5.2.2 Direct-to-Consumer
5.2.3 Subscription
5.2.4 Prescription Telemedicine Model
5.3 Product Mapping Analysis
6 MARKET DYNAMICS
6.1 Market Drivers
6.1.1 Growing Recognition of Women in the Domain of Technology
6.1.2 Economic Burden by Women’s Health is More Than $500 Billion
6.1.3 Explosion of Wearable Devices and Increasing Smartphone Penetration Among Women
6.2 Market Restraints
6.2.1 Lack of Women Decision Makers
6.2.2 Societal Taboos Surrounding Women’s Health Issues
6.2.3 Absence of Awareness Among Women in Rural Areas
6.2.4 Lack of Scientific Studies to Back Industrial Claims
6.2.5 Raising Capital and Workforce
6.2.6 Product Marketing in Femtech Space
6.3 Market Opportunities
6.3.1 Investment in Product Development for Maternal, Pre- and Neo-Natal Care
6.3.2 Investment in Sub-Saharan Africa
6.3.3 Product Development for Menopause Management
7 GLOBAL FEMTECH MARKET
7.1 Assumptions and Limitations
7.2 Key Findings and Opportunity Assessment
7.2.1 Key Findings
7.2.2 Opportunity Assessment
8 GLOBAL FEMTECH MARKET (BY COMPONENT)
8.1 Overview
8.2 Mobile Apps
8.3 Connected Devices
8.3.1 Wearable Connected Device
8.3.2 Non-Wearable Connected Device
8.4 Services
8.5 Others (Organic, Smart Female Hygiene Products)
9 GLOBAL FEMTECH MARKET (BY APPLICATION)
9.1 Overview
9.2 Reproductive Health
9.2.1 Period Tracking
9.2.2 At-Home Fertility Tracking and Monitoring
9.3 General Wellness
9.3.1.1 Menopause
9.4 Pregnancy and Nursing Care
9.4.1 Pregnancy Care
9.4.2 Post Pregnancy Care
9.4.2.1 Post-Partum Depression
9.4.3 Breastfeeding
9.4.4 Others
9.5 Pelvic and Uterine Care
9.5.1 Pelvic Wellness
9.5.2 Menstrual Health
10 GLOBAL FEMTECH MARKET (BY END USER)
10.1 Overview
10.2 Individuals
10.3 Fertility Clinics
10.4 Hospitals and Research Institutes
10.5 Diagnostic Centers
11 GLOBAL FEMTECH MARKET (BY REGION)
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 Sweden
11.3.4 Spain
11.3.5 France
11.3.6 Netherlands
11.3.7 Rest-of-Europe
11.3.7.1 Switzerland
11.3.7.2 Belgium
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 South Korea
11.4.4 Australia
11.4.5 India
11.4.6 Rest-of-Asia-Pacific
11.4.6.1 New Zealand
11.5 Middle East, South Africa, and Latin America
11.5.1 Middle East
11.5.1.1 Israel
11.5.1.2 Saudi Arabia
11.5.1.3 UAE
11.5.2 South Africa
11.5.3 Latin America
11.5.3.1 Brazil
11.5.3.2 Mexico
11.5.4 Rest-of-Rest -of-the-World (Rest-of-RoW)
12 COMPANY PROFILES
12.1 Overview
12.2 ALYK, Inc.
12.2.1 Company Overview
12.2.2 Role of ALYK, Inc. in the Global Femtech Market
12.2.3 Recent Developments
12.2.4 SWOT Analysis: ALYK, Inc.
12.3 Aytu BioScience, Inc.
12.3.1 Company Overview
12.3.2 Role of Aytu Bioscience, Inc. in the Global Femtech Market
12.3.3 Financials
12.3.4 Key Insights About Financial Health of the Company
12.3.5 Recent Developments
12.3.6 SWOT Analysis
12.4 Biowink GmbH
12.4.1 Company Overview
12.4.2 Role of Biowink GmbH in the Global Femtech Market
12.4.3 Recent Developments
12.4.4 SWOT Analysis: Biowink GmbH
12.5 Bloomlife
12.5.1 Company Overview
12.5.2 Role of Bloomlife GmbH in the Global Femtech Market
12.5.3 Recent Developments
12.5.4 SWOT Analysis: Bloomlife
12.6 CORA
12.6.1 Company Overview
12.6.2 Role of CORA in the Global Femtech Market
12.6.3 Recent Developments
12.6.4 SWOT Analysis: CORA
12.7 Flo Health, Inc.
12.7.1 Company Overview
12.7.2 Role of Flo Health Inc. in the Global Femtech Market
12.7.3 Recent Developments
12.7.4 SWOT Analysis: Flo Health Inc.
12.8 Glow, Inc.
12.8.1 Company Overview
12.8.2 Role of Glow, Inc. in the Global Femtech Market
12.8.3 Recent Developments
12.8.4 SWOT Analysis: Glow, Inc.
12.9 Inne
12.9.1 Company Overview
12.9.2 Role of Inne in the Global Femtech Market
12.9.3 Recent Developments
12.9.4 SWOT Analysis: Inne.
12.10 Kasha
12.10.1 Company Overview
12.10.2 Role of Kasha in the Global Femtech Market
12.10.3 Recent Developments
12.10.4 SWOT Analysis: Kasha
12.11 NaturalCycles Nordic AB
12.11.1 Company Overview
12.11.2 Role of NaturalCycles Nordic AB in the Global Femtech Market
12.11.3 Recent Developments
12.11.4 SWOT Analysis: NaturalCycels Nordic AB
12.12 Ovia Health
12.12.1 Company Overview
12.12.2 Role of Ovia Health Inc. in the Global Femtech Market
12.12.3 Recent Developments
12.12.4 SWOT Analysis: Ovia Health
12.13 Plackal Tech
12.13.1 Company Overview
12.13.2 Role of Plackal Tech in the Global Femtech Market
12.13.3 Recent Developments
12.13.4 SWOT Analysis: Plackal Tech.
12.14 Sustain Natural
12.14.1 Company Overview
12.14.2 Role of Sustain Natural in the Global Femtech Market
12.14.3 Recent Developments
12.14.4 SWOT Analysis: Sustain Natural
12.15 The Flex Company
12.15.1 Company Overview
12.15.2 Role of The Flex Company in the Global Femtech Market
12.15.3 Recent Developments
12.15.4 SWOT Analysis: The Flex Company
12.16 Thinx, Inc.
12.16.1 Company Overview
12.16.2 Role of Thinx Inc. in the Global Femtech Market
12.16.3 Recent Developments
12.16.4 SWOT Analysis: Thinx Inc.
12.17 Company Snapshots
12.17.1 Celmatix Inc.
12.17.1.1 Company Overview
12.17.1.2 Role of Celmatix Inc. in the Global Femtech Market
12.17.2 Conceivable Inc.
12.17.2.1 Company Overview
12.17.2.2 Role of Conceivable Inc. in the Global Femtech Market
12.17.3 Lia Diagnostics Inc.
12.17.3.1 Company Overview
12.17.3.2 Role of Lia Diagnostics Inc. in the Global Femtech Market
12.17.4 Lucina Health, Inc. (Subsidiary of Unified Women’s Healthcare, LLC)
12.17.4.1 Company Overview
12.17.4.2 Role of Lucina Health, Inc. in the Global Femtech Market
12.17.5 Progny, Inc.
12.17.5.1 Company Overview
12.17.5.2 Role of Progny, Inc. in the Global Femtech Market
12.17.6 Univfy Inc.
12.17.6.1 Company Overview
12.17.6.2 Role of Univfy Inc. in the Global Femtech Market
1 PRODUCT DEFINITION
1.1 Inclusion and Exclusion
2 SCOPE OF THE STUDY
2.1 Key Questions Answered in the Report
3 RESEARCH METHODOLOGY
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Companies Profiled
3.5 Assumptions and Limitations
4 INDUSTRY ANALYSIS
4.1 Industry Trends
4.1.1 Underrepresentation of Women as Decision Makers
4.1.2 Pricing and Branding Strategies
4.1.3 Femtech in Emerging Economies
4.1.4 Growing Emphasis on Holistic Women Healthcare
4.1.5 Smart Medical Devices and Wearables
4.1.6 Destigmatizing Menstrual Health and Menopause
4.2 Femtech Innovation Tracker
4.2.1 Wearable Devices for Fertility Tracking
4.2.2 Vaginal Sensor for Fertility Cycle Monitoring
4.2.3 Leveraging Genomics and Big Data for Fertility Tracking and Menstrual Health
4.2.4 Wearables for Breast Cancer Screening
4.3 Regulatory Framework
4.3.1 Regulatory Framework in North America
4.3.2 Regulatory Framework in Europe
4.4 Funding Analysis
4.4.1 Femtech Received More Than $1 Billion Over the Last 5 Years
4.4.2 Notable Private Funding in Femtech
5 COMPETITIVE LANDSCAPE
5.1 Key Developments and Strategies
5.1.1 Funding
5.1.2 Collaborations and Partnerships
5.1.3 Product Launch and Upgradation
5.1.4 Mergers and Acquisitions
5.2 Business Model Analysis
5.2.1 One-for-One Give Back Model
5.2.2 Direct-to-Consumer
5.2.3 Subscription
5.2.4 Prescription Telemedicine Model
5.3 Product Mapping Analysis
6 MARKET DYNAMICS
6.1 Market Drivers
6.1.1 Growing Recognition of Women in the Domain of Technology
6.1.2 Economic Burden by Women’s Health is More Than $500 Billion
6.1.3 Explosion of Wearable Devices and Increasing Smartphone Penetration Among Women
6.2 Market Restraints
6.2.1 Lack of Women Decision Makers
6.2.2 Societal Taboos Surrounding Women’s Health Issues
6.2.3 Absence of Awareness Among Women in Rural Areas
6.2.4 Lack of Scientific Studies to Back Industrial Claims
6.2.5 Raising Capital and Workforce
6.2.6 Product Marketing in Femtech Space
6.3 Market Opportunities
6.3.1 Investment in Product Development for Maternal, Pre- and Neo-Natal Care
6.3.2 Investment in Sub-Saharan Africa
6.3.3 Product Development for Menopause Management
7 GLOBAL FEMTECH MARKET
7.1 Assumptions and Limitations
7.2 Key Findings and Opportunity Assessment
7.2.1 Key Findings
7.2.2 Opportunity Assessment
8 GLOBAL FEMTECH MARKET (BY COMPONENT)
8.1 Overview
8.2 Mobile Apps
8.3 Connected Devices
8.3.1 Wearable Connected Device
8.3.2 Non-Wearable Connected Device
8.4 Services
8.5 Others (Organic, Smart Female Hygiene Products)
9 GLOBAL FEMTECH MARKET (BY APPLICATION)
9.1 Overview
9.2 Reproductive Health
9.2.1 Period Tracking
9.2.2 At-Home Fertility Tracking and Monitoring
9.3 General Wellness
9.3.1.1 Menopause
9.4 Pregnancy and Nursing Care
9.4.1 Pregnancy Care
9.4.2 Post Pregnancy Care
9.4.2.1 Post-Partum Depression
9.4.3 Breastfeeding
9.4.4 Others
9.5 Pelvic and Uterine Care
9.5.1 Pelvic Wellness
9.5.2 Menstrual Health
10 GLOBAL FEMTECH MARKET (BY END USER)
10.1 Overview
10.2 Individuals
10.3 Fertility Clinics
10.4 Hospitals and Research Institutes
10.5 Diagnostic Centers
11 GLOBAL FEMTECH MARKET (BY REGION)
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 Sweden
11.3.4 Spain
11.3.5 France
11.3.6 Netherlands
11.3.7 Rest-of-Europe
11.3.7.1 Switzerland
11.3.7.2 Belgium
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 South Korea
11.4.4 Australia
11.4.5 India
11.4.6 Rest-of-Asia-Pacific
11.4.6.1 New Zealand
11.5 Middle East, South Africa, and Latin America
11.5.1 Middle East
11.5.1.1 Israel
11.5.1.2 Saudi Arabia
11.5.1.3 UAE
11.5.2 South Africa
11.5.3 Latin America
11.5.3.1 Brazil
11.5.3.2 Mexico
11.5.4 Rest-of-Rest -of-the-World (Rest-of-RoW)
12 COMPANY PROFILES
12.1 Overview
12.2 ALYK, Inc.
12.2.1 Company Overview
12.2.2 Role of ALYK, Inc. in the Global Femtech Market
12.2.3 Recent Developments
12.2.4 SWOT Analysis: ALYK, Inc.
12.3 Aytu BioScience, Inc.
12.3.1 Company Overview
12.3.2 Role of Aytu Bioscience, Inc. in the Global Femtech Market
12.3.3 Financials
12.3.4 Key Insights About Financial Health of the Company
12.3.5 Recent Developments
12.3.6 SWOT Analysis
12.4 Biowink GmbH
12.4.1 Company Overview
12.4.2 Role of Biowink GmbH in the Global Femtech Market
12.4.3 Recent Developments
12.4.4 SWOT Analysis: Biowink GmbH
12.5 Bloomlife
12.5.1 Company Overview
12.5.2 Role of Bloomlife GmbH in the Global Femtech Market
12.5.3 Recent Developments
12.5.4 SWOT Analysis: Bloomlife
12.6 CORA
12.6.1 Company Overview
12.6.2 Role of CORA in the Global Femtech Market
12.6.3 Recent Developments
12.6.4 SWOT Analysis: CORA
12.7 Flo Health, Inc.
12.7.1 Company Overview
12.7.2 Role of Flo Health Inc. in the Global Femtech Market
12.7.3 Recent Developments
12.7.4 SWOT Analysis: Flo Health Inc.
12.8 Glow, Inc.
12.8.1 Company Overview
12.8.2 Role of Glow, Inc. in the Global Femtech Market
12.8.3 Recent Developments
12.8.4 SWOT Analysis: Glow, Inc.
12.9 Inne
12.9.1 Company Overview
12.9.2 Role of Inne in the Global Femtech Market
12.9.3 Recent Developments
12.9.4 SWOT Analysis: Inne.
12.10 Kasha
12.10.1 Company Overview
12.10.2 Role of Kasha in the Global Femtech Market
12.10.3 Recent Developments
12.10.4 SWOT Analysis: Kasha
12.11 NaturalCycles Nordic AB
12.11.1 Company Overview
12.11.2 Role of NaturalCycles Nordic AB in the Global Femtech Market
12.11.3 Recent Developments
12.11.4 SWOT Analysis: NaturalCycels Nordic AB
12.12 Ovia Health
12.12.1 Company Overview
12.12.2 Role of Ovia Health Inc. in the Global Femtech Market
12.12.3 Recent Developments
12.12.4 SWOT Analysis: Ovia Health
12.13 Plackal Tech
12.13.1 Company Overview
12.13.2 Role of Plackal Tech in the Global Femtech Market
12.13.3 Recent Developments
12.13.4 SWOT Analysis: Plackal Tech.
12.14 Sustain Natural
12.14.1 Company Overview
12.14.2 Role of Sustain Natural in the Global Femtech Market
12.14.3 Recent Developments
12.14.4 SWOT Analysis: Sustain Natural
12.15 The Flex Company
12.15.1 Company Overview
12.15.2 Role of The Flex Company in the Global Femtech Market
12.15.3 Recent Developments
12.15.4 SWOT Analysis: The Flex Company
12.16 Thinx, Inc.
12.16.1 Company Overview
12.16.2 Role of Thinx Inc. in the Global Femtech Market
12.16.3 Recent Developments
12.16.4 SWOT Analysis: Thinx Inc.
12.17 Company Snapshots
12.17.1 Celmatix Inc.
12.17.1.1 Company Overview
12.17.1.2 Role of Celmatix Inc. in the Global Femtech Market
12.17.2 Conceivable Inc.
12.17.2.1 Company Overview
12.17.2.2 Role of Conceivable Inc. in the Global Femtech Market
12.17.3 Lia Diagnostics Inc.
12.17.3.1 Company Overview
12.17.3.2 Role of Lia Diagnostics Inc. in the Global Femtech Market
12.17.4 Lucina Health, Inc. (Subsidiary of Unified Women’s Healthcare, LLC)
12.17.4.1 Company Overview
12.17.4.2 Role of Lucina Health, Inc. in the Global Femtech Market
12.17.5 Progny, Inc.
12.17.5.1 Company Overview
12.17.5.2 Role of Progny, Inc. in the Global Femtech Market
12.17.6 Univfy Inc.
12.17.6.1 Company Overview
12.17.6.2 Role of Univfy Inc. in the Global Femtech Market
LIST OF TABLES
Table 1: Some of the largest rounds of funding received by Femtech companies in 2019 include:
Table 2: Global Femtech Market (by End User), $Million, 2019-2030
Table 4.1: Pricing and Branding Strategy in the Global Femtech Market
Table 4.2: Celmatix, Inc: Product Portfolio
Table 4.3: Regulatory Framework for Femtech Market in North America
Table 4.4: Regulatory Framework for Femtech Market in Europe
Table 4.5: Venture Capital Firms for Women Health
Table 4.6: Private Funding in Global Femtech Market, 2019
Table 5.1: Global Femtech Market, Products
Table 6.1: Prevalence of Diseases in Women, 2017
Table 6.2: Global Mobile Phone Adoption by Women
Table 8.1: Mobile Applications for Women Reproductive Health
Table 8.1: Femtech Integration in Fertility Treatment
Table 9.1: Competitive Analysis
Table 9.2: Leading Products
Table 9.3: The size of healthcare burden of certain conditions that can be attributed to Menopause
Table 9.4: Wearables for Pregnancy Care
Table 9.5: Leading Solutions Developed by Healthcare Organizations for Gestational Diabetes Mellitus (GDM) Monitoring
Table 9.6: Salient Features of Freely Available Mobile Apps That Help Women to Ease into Postpartum
Table 10.1: Privacy Policy Analysis
Table 11.1: Breakdown of Funding Under National Women’s Health Strategy 2020-2030
Table 11.2: Other Innovative Femtech Start-Ups in Israel
Table 1: Some of the largest rounds of funding received by Femtech companies in 2019 include:
Table 2: Global Femtech Market (by End User), $Million, 2019-2030
Table 4.1: Pricing and Branding Strategy in the Global Femtech Market
Table 4.2: Celmatix, Inc: Product Portfolio
Table 4.3: Regulatory Framework for Femtech Market in North America
Table 4.4: Regulatory Framework for Femtech Market in Europe
Table 4.5: Venture Capital Firms for Women Health
Table 4.6: Private Funding in Global Femtech Market, 2019
Table 5.1: Global Femtech Market, Products
Table 6.1: Prevalence of Diseases in Women, 2017
Table 6.2: Global Mobile Phone Adoption by Women
Table 8.1: Mobile Applications for Women Reproductive Health
Table 8.1: Femtech Integration in Fertility Treatment
Table 9.1: Competitive Analysis
Table 9.2: Leading Products
Table 9.3: The size of healthcare burden of certain conditions that can be attributed to Menopause
Table 9.4: Wearables for Pregnancy Care
Table 9.5: Leading Solutions Developed by Healthcare Organizations for Gestational Diabetes Mellitus (GDM) Monitoring
Table 9.6: Salient Features of Freely Available Mobile Apps That Help Women to Ease into Postpartum
Table 10.1: Privacy Policy Analysis
Table 11.1: Breakdown of Funding Under National Women’s Health Strategy 2020-2030
Table 11.2: Other Innovative Femtech Start-Ups in Israel
LIST OF FIGURES
Figure 1: Global Female Income to Reach $26 Trillion by the End of 2020
Figure 2: Average Health Spending by Age and Gender, 2016
Figure 3: Global Femtech Market, $Million, 2018-2030
Figure 4: Global Femtech Market (by Component Type), Percent Share (%), 2019 and 2030
Figure 5: Global Femtech Market (by Region), $Million, 2019, 2025 and 2030
Figure 2.1: Global Femtech Market Segmentation
Figure 3.1: Global Femtech Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Venture Capital Firms Deal Count, 2008-2018
Figure 5.1: Share of Key Developments and Strategies, January 2016-March 2020
Figure 5.2: Funding Activity Share (by Company), January 2016-March 2020
Figure 5.3: Collaborations and Partnerships Share (by Company), January 2016-March 2020
Figure 5.4: Product Launches (by Company), January 2016-March 2020
Figure 5.5: Mergers and Acquisitions (by Company), January 2016- March 2020
Figure 5.6: Global Femtech Market, Product Mapping Analysis, 2019
Figure 6.1: Women Health Expenditure in the U.S., $Million, 2016-2020
Figure 6.2: Global Wearable Device Adoption by Women, 2018
Figure 8.1: Global Femtech Market (by Component)
Figure 8.2: Global Femtech Market (Apps), 2018-2030
Figure 8.3: Workflow in a Period Tracking Application
Figure 8.4: Global Femtech Market (Connected Devices), 2018-2030
Figure 8.5: Global Femtech Market (Services), 2018-2030
Figure 8.6: Global Femtech Market (Others), 2018-2030
Figure 9.1: Global Femtech Market (by Application)
Figure 9.2: Global Femtech Market (Reproductive Health), 2018-2030
Figure 9.3: Global Femtech Market (General Wellness), 2018-2030
Figure 9.4: Global Femtech Market (Pregnancy and Nursing Care), 2018-2030
Figure 9.5: Global Femtech Market (Pelvic and Uterine Care), 2018-2030
Figure 10.1: Global Femtech Market ( Individual Users), 2018-2030
Figure 10.2: Global Femtech Market (Fertility Clinics), 2018-2030
Figure 10.3: Global Femtech Market (Hospitals and Research Institutes), 2018-2030
Figure 10.4: Global Femtech Market (Diagnostic Centers), 2018-2030
Figure 11.1: Global Femtech Market (by Region)
Figure 11.2: North America Femtech Market, 2018-2030
Figure 11.3: North America: Market Dynamics
Figure 11.4: U.S. Femtech Market, 2018-2030
Figure 11.5: Canada Femtech Market, 2018-2030
Figure 11.6: Europe Femtech Market, 2018-2030
Figure 11.7: Europe: Market Dynamics
Figure 11.8: Germany Femtech Market, 2018-2030
Figure 11.9: U.K. Femtech Market, 2018-2030
Figure 11.10: Sweden Femtech Market, 2018-2030
Figure 11.11: Spain Femtech Market, 2018-2030
Figure 11.12: France Femtech Market, 2018-2030
Figure 11.13: Netherlands Femtech Market, 2018-2030
Figure 11.14: Rest-of-Europe Femtech Market, 2018-2030
Figure 11.15: Asia-Pacific Femtech Market, 2018-2030
Figure 11.16: Asia-Pacific: Market Dynamics
Figure 11.17: China Femtech Market, 2018-2030
Figure 11.18: Japan Femtech Market, 2018-2030
Figure 11.19: South Korea Femtech Market, 2018-2030
Figure 11.20: Australia Femtech Market, 2018-2030
Figure 11.21: India Femtech Market, 2018-2030
Figure 11.22: Rest-of-Asia-Pacific Femtech Market, 2018-2030
Figure 11.23: Rest-of-the-World Femtech Market, 2018-2030
Figure 11.24: Middle East, Africa, and Latin America: Market Dynamics
Figure 11.25: Israel Femtech Market, 2018-2030
Figure 11.26: Saudi Arabia Femtech Market, 2018-2030
Figure 11.27: UAE Femtech Market, 2018-2030
Figure 11.28: South Africa Femtech Market, 2018-2030
Figure 11.29: Brazil Femtech Market, 2018-2030
Figure 11.30: Mexico Femtech Market, 2018-2030
Figure 11.31: Rest-of-RoW Femtech Market, 2018-2030
Figure 12.1: ALYK, Inc.: Product Portfolio for the Global Femtech Market
Figure 12.2: ALYK,Inc.: SWOT Analysis
Figure 12.3: Aytu Bioscience, Inc.: Product Portfolio for Global Femtech Market
Figure 12.4: Aytu Bioscience: Overall Financials, 2016-2018
Figure 12.5: Aytu Bioscience, Inc. Revenue (by Region), 2017-2018
Figure 12.6: Aytu Bioscience, Inc. R&D Expenditure, 2016-2018
Figure 12.7: Aytu Bioscience, Inc: SWOT Analysis
Figure 12.8: Biowink GmbH: Product Portfolio for the Global Femtech Market
Figure 12.9: Biowink GmbH.: SWOT Analysis
Figure 12.10: Bloomlife: Product Portfolio for the Global Femtech Market
Figure 12.11: Bloomlife.: SWOT Analysis
Figure 12.12: CORA.: Product Portfolio for the Global Femtech Market
Figure 12.13: CORA SWOT Analysis
Figure 12.14: Flo Health Inc.: Product Portfolio for the Global Femtech Market
Figure 12.15: Flo Health Inc.: SWOT Analysis
Figure 12.16: Glow, Inc.: Product Portfolio for the Global Femtech Market
Figure 12.17: Glow, Inc.: SWOT Analysis
Figure 12.18: Inne.: Product Portfolio for the Global Femtech Market
Figure 12.19: Inne. SWOT Analysis
Figure 12.20: Kasha.: Product Portfolio for the Global Femtech Market
Figure 12.21: Kasha SWOT Analysis
Figure 12.22: NaturalCycles Nordic AB.: Product Portfolio for the Global Femtech Market
Figure 12.23: NaturalCycels Nordic AB: SWOT Analysis
Figure 12.24: Ovia Health.: Product Portfolio for the Global Femtech Market
Figure 12.25: Ovia Health: SWOT Analysis
Figure 12.26: Plackal Tech: Product Portfolio for the Global Femtech Market
Figure 12.27: Plackal Tech.: SWOT Analysis
Figure 12.28: Sustain Natural.: Product Portfolio for the Global Femtech Market
Figure 12.29: Sustain Natural SWOT Analysis
Figure 12.30: The Flex Company.: Product Portfolio for the Global Femtech Market
Figure 12.31: The Flex Company SWOT Analysis
Figure 12.32: Thinx Inc..: Product Portfolio for the Global Femtech Market
Figure 12.33: Thinx Inc. SWOT Analysis
Figure 1: Global Female Income to Reach $26 Trillion by the End of 2020
Figure 2: Average Health Spending by Age and Gender, 2016
Figure 3: Global Femtech Market, $Million, 2018-2030
Figure 4: Global Femtech Market (by Component Type), Percent Share (%), 2019 and 2030
Figure 5: Global Femtech Market (by Region), $Million, 2019, 2025 and 2030
Figure 2.1: Global Femtech Market Segmentation
Figure 3.1: Global Femtech Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Venture Capital Firms Deal Count, 2008-2018
Figure 5.1: Share of Key Developments and Strategies, January 2016-March 2020
Figure 5.2: Funding Activity Share (by Company), January 2016-March 2020
Figure 5.3: Collaborations and Partnerships Share (by Company), January 2016-March 2020
Figure 5.4: Product Launches (by Company), January 2016-March 2020
Figure 5.5: Mergers and Acquisitions (by Company), January 2016- March 2020
Figure 5.6: Global Femtech Market, Product Mapping Analysis, 2019
Figure 6.1: Women Health Expenditure in the U.S., $Million, 2016-2020
Figure 6.2: Global Wearable Device Adoption by Women, 2018
Figure 8.1: Global Femtech Market (by Component)
Figure 8.2: Global Femtech Market (Apps), 2018-2030
Figure 8.3: Workflow in a Period Tracking Application
Figure 8.4: Global Femtech Market (Connected Devices), 2018-2030
Figure 8.5: Global Femtech Market (Services), 2018-2030
Figure 8.6: Global Femtech Market (Others), 2018-2030
Figure 9.1: Global Femtech Market (by Application)
Figure 9.2: Global Femtech Market (Reproductive Health), 2018-2030
Figure 9.3: Global Femtech Market (General Wellness), 2018-2030
Figure 9.4: Global Femtech Market (Pregnancy and Nursing Care), 2018-2030
Figure 9.5: Global Femtech Market (Pelvic and Uterine Care), 2018-2030
Figure 10.1: Global Femtech Market ( Individual Users), 2018-2030
Figure 10.2: Global Femtech Market (Fertility Clinics), 2018-2030
Figure 10.3: Global Femtech Market (Hospitals and Research Institutes), 2018-2030
Figure 10.4: Global Femtech Market (Diagnostic Centers), 2018-2030
Figure 11.1: Global Femtech Market (by Region)
Figure 11.2: North America Femtech Market, 2018-2030
Figure 11.3: North America: Market Dynamics
Figure 11.4: U.S. Femtech Market, 2018-2030
Figure 11.5: Canada Femtech Market, 2018-2030
Figure 11.6: Europe Femtech Market, 2018-2030
Figure 11.7: Europe: Market Dynamics
Figure 11.8: Germany Femtech Market, 2018-2030
Figure 11.9: U.K. Femtech Market, 2018-2030
Figure 11.10: Sweden Femtech Market, 2018-2030
Figure 11.11: Spain Femtech Market, 2018-2030
Figure 11.12: France Femtech Market, 2018-2030
Figure 11.13: Netherlands Femtech Market, 2018-2030
Figure 11.14: Rest-of-Europe Femtech Market, 2018-2030
Figure 11.15: Asia-Pacific Femtech Market, 2018-2030
Figure 11.16: Asia-Pacific: Market Dynamics
Figure 11.17: China Femtech Market, 2018-2030
Figure 11.18: Japan Femtech Market, 2018-2030
Figure 11.19: South Korea Femtech Market, 2018-2030
Figure 11.20: Australia Femtech Market, 2018-2030
Figure 11.21: India Femtech Market, 2018-2030
Figure 11.22: Rest-of-Asia-Pacific Femtech Market, 2018-2030
Figure 11.23: Rest-of-the-World Femtech Market, 2018-2030
Figure 11.24: Middle East, Africa, and Latin America: Market Dynamics
Figure 11.25: Israel Femtech Market, 2018-2030
Figure 11.26: Saudi Arabia Femtech Market, 2018-2030
Figure 11.27: UAE Femtech Market, 2018-2030
Figure 11.28: South Africa Femtech Market, 2018-2030
Figure 11.29: Brazil Femtech Market, 2018-2030
Figure 11.30: Mexico Femtech Market, 2018-2030
Figure 11.31: Rest-of-RoW Femtech Market, 2018-2030
Figure 12.1: ALYK, Inc.: Product Portfolio for the Global Femtech Market
Figure 12.2: ALYK,Inc.: SWOT Analysis
Figure 12.3: Aytu Bioscience, Inc.: Product Portfolio for Global Femtech Market
Figure 12.4: Aytu Bioscience: Overall Financials, 2016-2018
Figure 12.5: Aytu Bioscience, Inc. Revenue (by Region), 2017-2018
Figure 12.6: Aytu Bioscience, Inc. R&D Expenditure, 2016-2018
Figure 12.7: Aytu Bioscience, Inc: SWOT Analysis
Figure 12.8: Biowink GmbH: Product Portfolio for the Global Femtech Market
Figure 12.9: Biowink GmbH.: SWOT Analysis
Figure 12.10: Bloomlife: Product Portfolio for the Global Femtech Market
Figure 12.11: Bloomlife.: SWOT Analysis
Figure 12.12: CORA.: Product Portfolio for the Global Femtech Market
Figure 12.13: CORA SWOT Analysis
Figure 12.14: Flo Health Inc.: Product Portfolio for the Global Femtech Market
Figure 12.15: Flo Health Inc.: SWOT Analysis
Figure 12.16: Glow, Inc.: Product Portfolio for the Global Femtech Market
Figure 12.17: Glow, Inc.: SWOT Analysis
Figure 12.18: Inne.: Product Portfolio for the Global Femtech Market
Figure 12.19: Inne. SWOT Analysis
Figure 12.20: Kasha.: Product Portfolio for the Global Femtech Market
Figure 12.21: Kasha SWOT Analysis
Figure 12.22: NaturalCycles Nordic AB.: Product Portfolio for the Global Femtech Market
Figure 12.23: NaturalCycels Nordic AB: SWOT Analysis
Figure 12.24: Ovia Health.: Product Portfolio for the Global Femtech Market
Figure 12.25: Ovia Health: SWOT Analysis
Figure 12.26: Plackal Tech: Product Portfolio for the Global Femtech Market
Figure 12.27: Plackal Tech.: SWOT Analysis
Figure 12.28: Sustain Natural.: Product Portfolio for the Global Femtech Market
Figure 12.29: Sustain Natural SWOT Analysis
Figure 12.30: The Flex Company.: Product Portfolio for the Global Femtech Market
Figure 12.31: The Flex Company SWOT Analysis
Figure 12.32: Thinx Inc..: Product Portfolio for the Global Femtech Market
Figure 12.33: Thinx Inc. SWOT Analysis
